Effects of Portrayals of Successful Treatment and Role Fulfillment on Mental Illness Stigma

NCT ID: NCT06509386

Last Updated: 2025-01-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-15

Study Completion Date

2024-08-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to measure levels of mental illness stigma based on successful treatment and societal role fulfillment of the individual portrayed with mental illness.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to measure levels of mental illness stigma based on successful treatment and societal role fulfillment of the individual portrayed with mental illness. This study utilizes eight vignettes portraying two different mental illnesses (depression and schizophrenia), with one vignette giving no details about role fulfillment or treatment, another giving no details about role fulfillment but successful treatment, another giving details on role fulfillment but no treatment, and last giving details on both role fulfillment and successful treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mental Illness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Major Depressive Disorder without treatment or role fulfillment

Group Type EXPERIMENTAL

Major Depressive Disorder without treatment or role fulfillment

Intervention Type OTHER

Read vignette describing the condition and ask stigma questions.

Major Depressive Disorder with treatment but no role fulfillment

Group Type EXPERIMENTAL

Major Depressive Disorder with treatment but no role fulfillment

Intervention Type OTHER

Read vignette describing the condition and ask stigma questions.

Major Depressive Disorder without treatment but with role fulfillment

Group Type EXPERIMENTAL

Major Depressive Disorder without treatment but with role fulfillment

Intervention Type OTHER

Read vignette describing the condition and ask stigma questions.

Major Depressive Disorder with treatment and role fulfillment

Group Type EXPERIMENTAL

Major Depressive Disorder with treatment and role fulfillment

Intervention Type OTHER

Read vignette describing the condition and ask stigma questions.

Schizophrenia without treatment or role fulfillment

Group Type EXPERIMENTAL

Schizophrenia without treatment or role fulfillment

Intervention Type OTHER

Read vignette describing the condition and ask stigma questions.

Schizophrenia with treatment but no role fulfillment

Group Type EXPERIMENTAL

Schizophrenia with treatment but no role fulfillment

Intervention Type OTHER

Read vignette describing the condition and ask stigma questions.

Schizophrenia without treatment but with role fulfillment

Group Type EXPERIMENTAL

Schizophrenia without treatment but with role fulfillment

Intervention Type OTHER

Read vignette describing the condition and ask stigma questions.

Schizophrenia with treatment and role fulfillment

Group Type EXPERIMENTAL

Schizophrenia with treatment and role fulfillment

Intervention Type OTHER

Read vignette describing the condition and ask stigma questions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Major Depressive Disorder without treatment or role fulfillment

Read vignette describing the condition and ask stigma questions.

Intervention Type OTHER

Major Depressive Disorder with treatment but no role fulfillment

Read vignette describing the condition and ask stigma questions.

Intervention Type OTHER

Major Depressive Disorder without treatment but with role fulfillment

Read vignette describing the condition and ask stigma questions.

Intervention Type OTHER

Major Depressive Disorder with treatment and role fulfillment

Read vignette describing the condition and ask stigma questions.

Intervention Type OTHER

Schizophrenia without treatment or role fulfillment

Read vignette describing the condition and ask stigma questions.

Intervention Type OTHER

Schizophrenia with treatment but no role fulfillment

Read vignette describing the condition and ask stigma questions.

Intervention Type OTHER

Schizophrenia without treatment but with role fulfillment

Read vignette describing the condition and ask stigma questions.

Intervention Type OTHER

Schizophrenia with treatment and role fulfillment

Read vignette describing the condition and ask stigma questions.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All adults who consider Buyende District their primary residence and who are capable of providing consent

Exclusion Criteria

* Minors younger than 18 years of age
* Persons who do not consider Buyende District their primary place of residence
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yale University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yang Jae Lee, MD

Role: PRINCIPAL_INVESTIGATOR

Yale University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Empowerment to Heal - Uganda

Iganga, , Uganda

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Uganda

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2000034605_b

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Peer-led Psycho-education for Schizophrenia
NCT03246932 ACTIVE_NOT_RECRUITING NA
mHealth for Psychosis Help-seeking
NCT05905601 COMPLETED NA